öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÐ¤ÕÑÑï
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º119

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÂé×íѧ
Ñо¿ÁìÓò£º ÄÔËðÉËÓëÄÔ±£»¤
Ñо¿ÁìÓò£º ÄÔËðÉËÓëÄÔ±£»¤ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºxiaozhaoy2012@163.com


¸öÈ˼òÊö :
ФÕÑÑ²©Ê¿¡¢Ö÷ÈÎҽʦ¡¢Ë¶Ê¿Éúµ¼Ê¦¡¢Ñ§¿Æ´øÍ·ÈË£»ÏíÊܹúÎñÔºÕþ¸®ÌØÊâ½òÌùר¼Ò£»ÏÖÈδóÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½Ôº¼±Õïҽѧѧ¿ÆÖ÷Èμ漱ÕïICU¡¢´´É˼±Ö¢ÖÐÐÄÂé×íÖ÷ÈΡ£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð»ùÃæÉÏÏîÄ¿2ÏÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ð1Ïî¡£·¢±íѧÊõÂÛÎÄ30Óàƪ£¬ÆäÖÐSCIÊÕ¼ÂÛÎÄ13ƪ¡£ÆäÖÐ7ƪΪµÚÒ»×÷Õß»òͨѶ×÷Õߣ¬×ÜÓ°ÏìÒò×Ó35.232¡£»ñµÃ2ÏîʵÓÃÐÂÐÍרÀû¡£¡¶¹ú¼ÊÂé×íѧÓ븴ËÕ¡·ÔÓÖ¾±àί¡£2015Äê»ñµÃÁÉÄþÊ¡¿Æѧ¼¼ÊõÈýµÈ½±£¨ÅÅÃû£ºµÚÒ»Ãû£©¡¢Ò½Ôº¿Æ¼¼´´Ð½±ÈýµÈ½±£¨ÅÅÃû£ºµÚÒ»Ãû£©ºÍÁÉÄþҽѧ¿Æ¼¼½±£»2014ÄêÆÀΪÁÉÄþÊ¡ÅʵÇѧÕߣ»2011ÄêÑÇÌ«Âé×í´´ÐÂÕß½±»ñµÃÕß¡£µ£ÈÎ2015ÄêÖйúÆ÷¹ÙÒÆÖ²·¢Õ¹»ù½ð»áίԱ»áίԱ£¬2014Äê´óÁ¬Ò½Ñ§»á¼±Õï·Ö»á¸±Ö÷ÈÎίԱ¡¢ÁÉÄþÊ¡Éñ¾­¿Æѧѧ»áÀíʺÍÁÉÄþʡҽѧ»áÌÛÍ´·Ö»áίԱ»áίԱ¡£²Î±à¡¶Âé×íѧ¡·Ñо¿Éú½Ì²Ä¡£ÅàÑø˶ʿÑо¿Éú11ÈË¡£´ÓÊÂÁÙ´²¹¤×÷19Ä꣬Éó¤¸÷ÖÖ¸´ÔÓÊÖÊõÂé×íÓëΣÖز¡È˵ĸ´ËÕ¹ÜÀí¡£ÌرðÊÇÔÚB³¬Òýµ¼»ò¸¨ÖúϽøÐÐÓд´²Ù×÷¡¢Ðķι¦ÄÜÅжÏÖ¸µ¼Î£Öز¡»¼Õß¾ÈÖÎÓнÏÉîµÄÔìÒè¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿
£¨1£©.ñ²ðï·¢ÉúÓë·¢Õ¹ÖС°Ë«¿×¼ØͨµÀTREK-2ÏÙÜÕ¿ª·Å;¾¶¡±Ñо¿. 2010»ñ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð ÃæÉÏÏîÄ¿ 30Íò£¨µÚÒ»ÉêÇëÈË£¬»ù½ðºÅ£º** /2011.1- 2013.12£©
£¨2£©.Ë«¿×¼ØͨµÀTREK-1ÔÚÒì·úÃѹàÁ÷¶ÔCPBÐÄÔàÊÖÊõÖÐÄÔ±£»¤×÷Óü°»úÖÆ. 2014ÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ð5ÍòÔª£¨µÚÒ»ÉêÇëÈË£¬»ù½ðºÅ£º**/2014.7- 2017.7£©
£¨3£©.GABAB2ÊÜÌåÑÇ»ùµ÷¿ØË«¿×¼ØͨµÀTREKÑǼÒ×åÔÚÒÖÓôÖ¢·¢²¡»úÖƵÄ×÷ÓÃ. 2014»ñ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð ÃæÉÏÏîÄ¿ 70Íò£¨µÚÒ»ÉêÇëÈË£¬»ù½ðºÅ£º**/2015.1- 2018.12£©
´ú±íÎÄÕÂ
£¨1£©Li L, Deng B, Wang S, Zhong H, Liu Z, Jin W, Jiang T, Xiao Z, Wang Q. Aynchronous therapy targeting Nogo-A enhances neurobehavioral recovery by reducing neuronal loss and promoting neurite outgrowth after cerebral ischemia in mice. J Drug Target. 2015 ,10:1-11. ( Impact factor=2.743 ) ¹²Í¬Í¨Ñ¶×÷Õß
£¨2£©Xiao Z, Cilz N, Kurada L, Hu B, Yang C, Wada E, Combs C, Porter J, Lesage F, Lei S. Activation of Neurotensin Receptor 1 Induces Long-Term Neuronal Excitation and Facilitates Spatial Learning and Memory: Beneficial Actions in an Alzheimer's Disease. Journal of Neuroscience. 2014, 34(20), 7027-7042. ( Impact factor=6.704 ) µÚÒ»×÷Õß
£¨3£©Zhang HP, Xiao Z, Cilz NI, Hu B, Dong H, Lei S. Bombesin facilitates GABAergic transmission and depresses epileptiform activity in the entorhinal cortex. Hippocampus. 2014, 24(1):21-31. ( Impact factor=5.492 ) ¹²Í¬µÚÒ»×÷Õß
£¨4£©Xiao Z, Jaiswal MK, Deng PY, Matsui T, Shin HS, Porter JE, Lei S. Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior. Hippocampus. 2012, 22(6):1438-50. ( Impact factor=5.492 ) µÚÒ»×÷Õß
£¨5£©Hu S, Wang W, Wang C, Ma R, *Xiao Z, Dong H. Langerhans cells histiocytosis presenting as multisystem disorder in an infant: a case report. 201251:709-712 ( Impact factor=1.342 ) ͨѶ×÷Õß
£¨6£©Xiao Z, Deng PY, Rojanathammanee L, Yang C, Grisanti L, Permpoonputtana K, Weinshenker D, Doze VA, Porter JE, Lei S. Noradrenergic depression of neuronal excitability in the entorhinal cortex by activation of TREK-2 K+ channels. Journal of Biological Chemistry.2009, 284(16):10980-10990. (Impact factor=5.328) µÚÒ»×÷Õß
£¨7£©Xiao Z, Deng PY, Yang C, Lei S. Modulation of GABAergic transmission by muscarinic receptors in the entorhinal cortex of juvenile rats. Journal of Neurophysiology. 2009,102 (2): 659-69. ( Impact factor=3.483) µÚÒ»×÷Õß